Ranatensin (CAS 29451-71-6)

Ranatensin, a peptide originally isolated from the skin of certain frog species, has garnered significant interest in scientific research for its potential as a pharmacological tool and its implications in various physiological processes. One area of investigation involves exploring the mechanisms of action of ranatensin on the cardiovascular system. Research has demonstrated that ranatensin acts as an agonist for specific receptors, including the angiotensin II type 2 (AT2) receptor, exerting vasodilatory effects and modulating blood pressure regulation. Furthermore, studies have delved into the molecular interactions between ranatensin and its receptor targets, elucidating its role in intracellular signaling pathways and downstream cellular responses. Moreover, ranatensin has been utilized as a molecular probe in studies investigating the structure-activity relationships of peptide-receptor interactions. Additionally, research efforts have explored the potential neuroendocrine and behavioral effects of ranatensin, shedding light on its broader physiological functions beyond cardiovascular regulation. Overall, ranatensin serves as a valuable tool for studying peptide-receptor interactions and unraveling the complex mechanisms underlying cardiovascular physiology, offering insights into potential interventions for cardiovascular diseases.